An Fc-Engineered Glycomodified Antibody Supports Pro-inflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer: Fc Engineered Antibodies Restrict Breast Cancer Growth

by | Nov 15, 2025

An Fc-Engineered Glycomodified Antibody Supports Pro-inflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer: Fc Engineered Antibodies Restrict Breast Cancer Growth

Chenoweth, A., Cheung, A., Chauhan, J., Adams, R., Osborn, G., Stoker, K., Grandits, M., Laddach, R., Trendell, J., Navarro-Llinas, B., Suriawinata, E., Gross, A., Clarke, A., Brown, L., Cserny, J., Moise, L., Jatiani, S., McCraw, A., Esapa, B. & Haider, S. A. & 14 others, Quist, J., Ilieva, K., Davies, A. M., Romero Clavijo, P., Senard, T., Cheeseman, J., Gardner, R. A., Spencer, D. I. R., Tsoka, S., Irshad, S., McDonnell, J., Grigoriadis, A., Tutt, A. & Karagiannis, S. N., 15 Nov 2025, In: Cancer Research. 85, 22, p. 4521-4540 20 p., CAN-24-3174R2.

Research output: Contribution to journal › Article › peer-review